TriMas Co. (NASDAQ:TRS - Free Report) - Analysts at BWS Financial upped their Q1 2025 earnings estimates for TriMas in a research report issued on Thursday, January 23rd. BWS Financial analyst H. Khorsand now anticipates that the industrial products company will post earnings of $0.44 per share for the quarter, up from their prior estimate of $0.43. BWS Financial currently has a "Buy" rating and a $40.00 target price on the stock. The consensus estimate for TriMas' current full-year earnings is $1.69 per share. BWS Financial also issued estimates for TriMas' Q2 2025 earnings at $0.54 EPS, Q3 2025 earnings at $0.61 EPS, Q4 2025 earnings at $0.46 EPS and FY2025 earnings at $2.04 EPS.
Separately, StockNews.com upgraded TriMas from a "sell" rating to a "hold" rating in a research report on Wednesday, November 13th.
Check Out Our Latest Research Report on TRS
TriMas Stock Performance
Shares of NASDAQ TRS traded down $0.28 during trading on Monday, reaching $25.12. The stock had a trading volume of 347,181 shares, compared to its average volume of 233,236. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.44 and a current ratio of 2.83. The stock has a market cap of $1.02 billion, a PE ratio of 39.25 and a beta of 0.67. TriMas has a one year low of $22.24 and a one year high of $28.51. The firm's 50 day moving average price is $25.07 and its two-hundred day moving average price is $25.45.
TriMas (NASDAQ:TRS - Get Free Report) last posted its quarterly earnings results on Monday, November 4th. The industrial products company reported $0.43 EPS for the quarter, missing analysts' consensus estimates of $0.57 by ($0.14). TriMas had a return on equity of 9.21% and a net margin of 2.93%. The firm had revenue of $229.36 million during the quarter, compared to analyst estimates of $239.33 million. During the same quarter last year, the business posted $0.57 earnings per share. The firm's revenue for the quarter was down 2.5% on a year-over-year basis.
Institutional Trading of TriMas
Several hedge funds have recently bought and sold shares of TRS. JPMorgan Chase & Co. boosted its position in TriMas by 3.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 38,461 shares of the industrial products company's stock worth $982,000 after acquiring an additional 1,227 shares during the period. Barclays PLC raised its stake in shares of TriMas by 341.3% during the third quarter. Barclays PLC now owns 68,792 shares of the industrial products company's stock valued at $1,755,000 after purchasing an additional 53,203 shares in the last quarter. XTX Topco Ltd acquired a new stake in TriMas in the third quarter worth about $371,000. Jane Street Group LLC grew its position in TriMas by 74.4% in the 3rd quarter. Jane Street Group LLC now owns 82,621 shares of the industrial products company's stock valued at $2,109,000 after buying an additional 35,258 shares in the last quarter. Finally, Wellington Management Group LLP increased its stake in TriMas by 10.7% during the 3rd quarter. Wellington Management Group LLP now owns 2,619,359 shares of the industrial products company's stock valued at $66,872,000 after buying an additional 252,537 shares during the period. 99.42% of the stock is currently owned by institutional investors.
About TriMas
(
Get Free Report)
TriMas Corporation engages in the design, development, manufacture, and sale of products for consumer products, aerospace, and industrial markets worldwide. The company operates through Packaging, Aerospace, and Specialty Products segments. The Packaging segment offers dispensing products, such as foaming and sanitizer pumps, lotion and hand soap pumps, beverage dispensers, perfume sprayers, and nasal and trigger sprayers; polymeric and steel caps and closures comprising food lids, flip-top and beverage closures, child resistance caps, drum and pail closures, and flexible spouts; polymeric jar products; integrated dispensers; bag-in-box products; and consumable vascular delivery and diagnostic test components under the Rieke, Taplast, Affaba & Ferrari, Intertech, Omega, and Rapak brands.
See Also
Before you consider TriMas, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and TriMas wasn't on the list.
While TriMas currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.